EI
KYTH

EAM Investors’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

EAM Investors’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-55,201
Closed -$2.06M – 402
2013
Q4 		$2.06M Sell
55,201
-5,018
-8% -$208K 0.37% 82
2013
Q3 		$2.75M Buy
+60,219
New +$1.8M 0.55% 34

Other funds holding KYTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

EAM Investors's KYTH Position: Q1 2014 in Review

EAM Investors sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q1 2014, closing a stake of 55,201 shares — an estimated $2.06M sold.

EAM Investors first reported a position in KYTH in Q3 2013 and held it in 2 quarters. The position peaked at $2.75M in Q3 2013. 102 funds tracked by Wall St. Rank hold KYTH as of Q1 2014.

  • EAM Investors reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q1 2014 after selling out during the quarter.
  • EAM Investors sold 55,201 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q1 2014, an estimated $2.06M.
  • EAM Investors first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 2 quarters.
  • EAM Investors's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $2.75M in Q3 2013.
  • 102 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2014.

Based on EAM Investors's 13F filing for Q1 2014, filed 15 May 2014.